Vertex has entered a reimbursement agreement with NHS England enabling eligible SCD patients to access Casgevy in the public ...
KODATEF is not approved for use in the U.S. Demand for ARAKODA has been steadily growing in recent months as awareness and ...
Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...
Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen to all the different tissues in your body and removing carbon dioxide to ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
With 52% of children in Punjab suffering from anemia, 49% facing vitamin A deficiency, and over 70% lacking sufficient vitamin D, health experts emphasise that mandatory food fortification is the only ...
The following is a summary of “Regional differences in triage decisions affect hospital mortality among frail COVID-19 patients in the COvid MEdicaTion study,” published in the February 2025 issue of ...
For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...
1d
Hosted on MSNBlood disorder impacts hundreds of IN residents, women of colorThe Centers for Disease Control and Prevention report the life-shortening blood disease sickle cell anemia affects about ...
Gluten is a protein in wheat, barley, and rye and is associated with two dietary conditions, celiac disease and non-celiac ...
Patients with BRAF V600E-mutated metastatic colorectal cancer experienced improved responses when treated with Braftovi plus Erbitux and mFOLFOX6.
Background Iron deficiency (ID) is common in patients with atrial fibrillation/flutter (AF), but its prognostic implications and optimal diagnostic criteria, particularly in those with and without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results